Development of a PAE-based nomogram to predict severe endocrine dysfunction after craniopharyngioma resection in

Jiahao Niu1, Ying Guo2, Wentao Zhou1,3

  • 1Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, 119 South 4th Ring West Road, Fengtai District, Beijing, 100070, China.

Neurosurgical Review
|December 1, 2025
PubMed

Insights

A new nomogram using the Pediatric Anatomo-Endocrine (PAE) classification helps predict severe endocrine dysfunction after pediatric craniopharyngioma surgery, aiding surgical planning and risk assessment.

Area of Science:

  • Pediatric Endocrinology
  • Neurosurgery
  • Oncology

Background:

  • Craniopharyngioma (CP) resection in children frequently leads to severe postoperative endocrine dysfunction.
  • Accurate prediction of this dysfunction is crucial for surgical planning and patient management.

Purpose of the Study:

  • To develop and validate a Pediatric Anatomo-Endocrine (PAE)-based nomogram for predicting severe postoperative endocrine dysfunction in pediatric CP patients.
  • To integrate anatomical classification, surgical factors, and baseline endocrine status into a predictive model.

Main Methods:

  • Retrospective analysis of 370 pediatric CP patients (≤18 years) undergoing primary resection.
  • Development of a three-tier PAE classification based on preoperative MRI.
  • Logistic regression to identify predictors of severe dysfunction, followed by nomogram construction and validation (ROC, calibration, decision curve analyses).

Main Results:

  • 83.4% of patients experienced worsened endocrine dysfunction postoperatively; severe dysfunction increased from 20.3% to 79.3%.
  • Independent predictors included PAE classification, baseline endocrine status, and pituitary stalk sacrifice.
  • The nomogram showed strong predictive performance (AUC 0.84 primary, 0.82 validation); the Global PAE subtype had the highest risk (OR 16.30).

Conclusions:

  • The PAE classification effectively stratifies hypothalamic-pituitary involvement and predicts endocrine outcomes.
  • The developed nomogram offers a practical tool for individualized risk prediction and surgical planning in pediatric CP.
  • External multicenter validation is recommended to confirm generalizability and long-term benefits.